Company description
The identification of biomarkers from pathogens is a prerequisite for the development of vaccines and diagnostic assays. Creative Biolabs developed an extensive and comprehensive strategy, named ORFeome phage display, for the identification of biomarkers related to pathogens. We apply this technology to identify new biomarkers by using bacterial genome libraries. We are proud to introduce this service for new biomarkers identification to all our global customers.
